BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18505404)

  • 1. Erythropoietin and the endothelium - a promising link?
    Fliser D; Bahlmann FH
    Eur J Clin Invest; 2008 Jul; 38(7):457-61. PubMed ID: 18505404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and treatment of non-anemic conditions--cardiovascular protection.
    Fliser D; Haller H
    Semin Hematol; 2007 Jul; 44(3):212-7. PubMed ID: 17631185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of disease: erythropoietin--an old hormone with a new mission?
    Fliser D; Bahlmann FH; deGroot K; Haller H
    Nat Clin Pract Cardiovasc Med; 2006 Oct; 3(10):563-72. PubMed ID: 16990842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients.
    Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E
    Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
    van der Meer P; Lipsic E; Henning RH; de Boer RA; Suurmeijer AJ; van Veldhuisen DJ; van Gilst WH
    Eur J Heart Fail; 2004 Dec; 6(7):853-9. PubMed ID: 15556046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat.
    di Villa Bianca Rd; Sorrentino R; Mitidieri E; Marzocco S; Autore G; Thiemermann C; Pinto A; Sorrentino R
    Shock; 2009 May; 31(5):529-34. PubMed ID: 18838949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin-dependent endothelial proteins: potential use against erythropoietin resistance.
    Congote LF; Sadvakassova G; Dobocan MC; Difalco MR; Li Q
    Cytokine; 2010 Aug; 51(2):113-8. PubMed ID: 20399679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
    Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
    Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute erythropoietin cardioprotection is mediated by endothelial response.
    Teng R; Calvert JW; Sibmooh N; Piknova B; Suzuki N; Sun J; Martinez K; Yamamoto M; Schechter AN; Lefer DJ; Noguchi CT
    Basic Res Cardiol; 2011 May; 106(3):343-54. PubMed ID: 21347618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of erythropoietin in brain homeostasis, neurodevelopment and neuroprotection].
    Kocsis I; Treszl A; Vásárhelyi B
    Orv Hetil; 2005 Dec; 146(50):2527-32. PubMed ID: 16440497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
    Harder Y; Amon M; Schramm R; Contaldo C; Metzkow E; Matzen A; Rücker M; Vollmar B; Menger MD
    Surgery; 2009 Apr; 145(4):372-83. PubMed ID: 19303985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle.
    Mannello F; Tonti GA
    Oncologist; 2008 Jul; 13(7):761-8. PubMed ID: 18596367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin action in stress response, tissue maintenance and metabolism.
    Zhang Y; Wang L; Dey S; Alnaeeli M; Suresh S; Rogers H; Teng R; Noguchi CT
    Int J Mol Sci; 2014 Jun; 15(6):10296-333. PubMed ID: 24918289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin and renoprotection.
    Bahlmann FH; Fliser D
    Curr Opin Nephrol Hypertens; 2009 Jan; 18(1):15-20. PubMed ID: 19077684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of protective action of erythropoietin in cells].
    Borysewicz-Sańczyk H; Szczepański M
    Pol Merkur Lekarski; 2011 Jan; 30(175):56-61. PubMed ID: 21542247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.
    Brines M; Cerami A
    J Intern Med; 2008 Nov; 264(5):405-32. PubMed ID: 19017170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine function of erythropoietin in IGF-1-induced erythropoietin biosynthesis.
    Kim I; Kim CH; Yim YS; Ahn YS
    Neuroreport; 2008 Nov; 19(17):1699-703. PubMed ID: 18841090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibility.
    Carruthers SG
    Clin Pharmacol Ther; 2009 Aug; 86(2):134-6. PubMed ID: 19621008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin--role in vascular disease.
    Abraham D; Dashwood M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice.
    Yoshimi M; Maeyama T; Yamada M; Hamada N; Fukumoto J; Kawaguchi T; Kuwano K; Nakanishi Y
    Respirology; 2008 Sep; 13(5):639-45. PubMed ID: 18713087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.